GSK meets Belgian Universities (UPDATED)

NOTE: Event rescheduled from 23 April to 27 October 2020. The organizing committee has decided to switch the format to a virtual format.

Please keep in mind that those who already registered for the event on April 23, will need to re-register for the new date.

The 3rd edition of the GSK Meets Belgian Universities event organized with the support of BioWin, and Flanders Vaccine will go ahead as a virtual event on Tuesday 27th October. The presentations and pre-recorded pitches will be streamed to you via Microsoft Teams from a studio at GSK, Wavre. The link will be sent to participants by email the day before the Event.

The deadline for registration is October 13, 2020.



09.15 – 09.30h. Introduction

09.30 – 10.45h. Plenary: Crohn’s disease – Is there room for a vaccine?

  • Disease overview & role of the microbiome (Joao Sabino, KUL)
  • Genetic & environmental risk factors (Claire Liefferinckx, ULB)
  • Opportunity for a therapeutic vaccine (Vincent Verlant, GSK)

10.45 – 11.00h. Break

11.00 – 13.00h. University Elevator Pitches

13.00 – 14.00h. Lunch

14.00 – 15.00h. Plenary: Future Trends Session
by Koen Kas, Healthcare Futurist & Delight Thinker

15.00 – 15.15h. Announcement of the 4 winning University Elevator Pitches

15.15 – 15.30h. Closing remarks


Pitch your innovative ideas

The deadline for abstracts is closed.

Thanks to those who submitted an abstract.

Important: The Event is a NON-CONFIDENTIAL forum for discussion and exchange of scientific information and knowledge. As such, information presented or otherwise disclosed by participants and/or exchanged during discussion at the Event shall NOT BE CONFIDENTIAL and shall therefore not be subject to any confidentiality obligations.


Target Audience

Belgian University scientists



Participation at this event is free of charge but registration is mandatory.

We would highly appreciate being informed about any cancellation.

The deadline for registration is October 13, 2020.



For more information or questions, please contact:

Fran Van Heuverswyn, Flanders Vaccine,
Katrien Lorré,,
Joëlle Gahimbare, BioWin,

BioWin thanks LIEU (Liaison Entreprises-Universités) for its help.